If you liked this article you might like

Andrew Left Says Mallinckrodt's Key Drug Could Be in Jeopardy
Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
Mallinckrodt's Top Drug Could Go the Way of EpiPen
Mallinckrodt (MNK) Stock Climbs on Nuclear Imaging Business Sale